of Drugs: Topoisomerase
Not approved - still in trials
on Patient Assistance program: N/A
is a water insoluble camptothecin derivative.
A novel derivative of camptothecin, 9-aminocamptothecin
(9-AC), is currently under Phase II evaluation in various cancers.
This medication is in clinical trials to treat breast and colon
cancers, malignant melanoma, small-cell lung cancer, and leukemia.
None yet - still in trials.
yet - still in trials.
to Drug Index
information is intended as reference and not as medical advice.
All treatment decisions should be made with your team of medical
professionals and prescriptions must be given by your doctor.